{{Message}}

Press contact

  • image Mail address: pers@mediq.com
  • image Ragna Ouwerkerk +31 (0)6 1152 6106

Utrecht, 7 April 2021 Mediq has successfully raised new funding in order to finance its continued European expansion as a healthcare and homecare partner. Mediq has secured new longterm financing to replace existing debt facilities that will allow the company to continue to pursue its growth path. Advent International, one of the world’s largest private equity firms, will continue to support Mediq throughout its next phase of growth.

Over the last two years, Mediq has strengthened its European footprint through a string of acquisitions, such as that of Replant 4 Care in Hungary, H&R Healthcare in the United Kingdom, Norway’s Puls AS and last month Medirum AB in Sweden. In the Netherlands, Mediq aims to acquire Eurocept Homecare and Da Vinci Kliniek, which will add around 400 employees to the Benelux-team. The company is steadily transforming from a wholesale business to a healthcare solutions and service provider. “Advent has been a very valuable and supportive strategic partner since they came onboard. We are proud of the vote of confidence by this high quality investor who shares our vision”, says Christian Wojczewski, Mediq’s CEO.

"Mediq is performing well and successfully executing on its growth ambitions. We are pleased to have strengthened our commitment to a company that supports healthcare institutions and professionals to provide the best possible care, and helps patients to self-manage chronic diseases. Staying ahead in the healthcare industry means offering value beyond medical products and addressing issues such as affordability of quality healthcare. Mediq is well positioned to play a leading role in this challenging environment”, commented Tom Allen, Managing Director of Advent International.

At Mediq, we want to help shape a better and healthier world by developing healthcare solutions that can be incorporated into everyday patient lives. We regularly undertake initiatives to achieve our main CSR goals of health system strengthening and patient empowerment & well-being. A great example is the DiaCare program that strengthens outpatient diabetes care. By connecting people, technology and data, the program helps care providers meet the Quadruple Aim: an improved patient experience, better health outcomes, an improved staff experience and lower cost of care.

Diabetes is a chronic, metabolic disease which leads over time to serious damage to the heart, blood vessels, eyes, kidneys and nerves. The most common is type 2 diabetes, which occurs when the body becomes resistant to insulin or doesn't make enough insulin. Type 1 diabetes is a chronic condition in which the pancreas produces little or no insulin by itself. About 422 million people worldwide have diabetes. Both the number of cases and the prevalence of diabetes have been steadily increasing over the past few decades. There is a globally agreed target to halt the rise in diabetes and obesity by 2025.

Meeting tomorrow’s healthcare needs
To expand today’s capacity and capabilities to match tomorrow’s needs, health systems need to embrace change. Mediq’s DiaCare program extends care delivery by providing smarter and more efficient care processes with better collaboration between diabetes nurses and patients. The DiaCare app provides patients with insights into their blood sugar levels and helps them prepare for consultations. Patients can also use e-learning modules to supplement their knowledge on subjects such as nutrition, self-regulation, sports and exercise, and carbohydrates. Healthcare professionals can use the DiaCare portal to monitor patients’ values and help patients faster. DiaCare also supports video calling via a secure connection.

Accomplishments and feedback
DiaCare was introduced in the Netherlands in 2017. Since then, 35 healthcare institutions became involved in the program with around 3.200 registered diabetes patients and 260 active users per month. Approximately 75% of the patients report blood glucose value levels within a healthy range. ‘Professionals and patients tell us that they especially appreciate the function of consult preparation. Patients enjoy knowing what to discuss in advance and professionals find it helpful that they can easily view a patient’s health data’, says Matthijs van Hagen, e-business specialist at Mediq.

DiaCare advantages:
•    Improved patient awareness and therapy compliance
•    Smarter and more efficient care process
•    Less risks of developing complications
•    Better health outcomes
•    Lower healthcare costs


Utrecht, 9 March 2021 – Mediq has acquired Medirum AB, a leading provider of medical technology solutions and products for hospitals and healthcare facilities in Sweden. The Gothenburg-based company’s customers include the largest hospitals in the country. ‘Together with Medirum’s highly skilled employees we can strengthen our hospital equipment and solutions offering in Sweden. With their innovative solutions, products and services, we take another important step in our transformation to value-adding medical service provider’, says Christian Wojczewski, Mediq’s CEO.

Strong strategic fit
Medirum offers turnkey operation room solutions to serve the needs of surgical, intensive care, emergency and X-ray departments. The acquisition is a strong strategic fit with Mediq’s ambition to support healthcare institutions and professionals to provide best possible care. According to Peter Andreasson, CEO of Medirum AB, both companies have the same vision on the future of healthcare. ‘By joining forces we can add even greater value for our customers.’

About Medirum
Medirum AB was founded 2003 in Gothenburg and is active throughout the whole of Sweden. The main customers are surgical departments, intensive care, emergency and X-ray departments. They currently deliver to the largest hospitals in Sweden.

Utrecht, 8 January 2021 – Mediq has acquired GD Medical AG, a Switzerland-based distributor of medical devices and supplies for intensive, anesthesia and general care units of hospitals. GD Medical’s portfolio includes innovative products such as blood purification, blood and fluid warming systems, respiratory care, wound care products, pain relief medication pumps and neuromuscular monitoring devices. ‘This acquisition fits perfectly with our strategy to be a leading European provider of medical devices and healthcare products and services for both healthcare institutions and patients’, says Mediq CEO Christian Wojczewski.

GD Medical’s activities are fully complementary to the activities of Mediq Suisse to deliver medical products for ostomy, continence and wound care as well as nursing and facility products. Through its exclusive distributor relations, GD Medical provides a unique assortment of high quality products. Their employees are at the forefront of exciting innovations and have a lot of technical competence. Both teams are excited about this step as it helps us to add value for our customers and to expand our presence in Switzerland.

About GD Medical AG
Based in Freienbach near Zurich, GD Medical AG was founded in 2006 by Gabriel Dürst, who set out to supply hospitals with a range of medical consumables and intensive and general care devices and equipment to support the wellbeing needs of patients. Further information is available at https://gdmedical.ch/.

About Mediq
Every day, millions of patients and the dedicated professionals who care for them rely on the supply of medical devices and care solutions from Mediq. As a reliable partner for patients, healthcare professionals and healthcare insurers, Mediq continuously focuses on improving healthcare outcomes and the affordability of healthcare. Mediq was founded in 1899 and has leading market positions in 13 European countries. The head office is located in Utrecht.

Utrecht, 4 January 2021 – Mediq, leading provider of medical devices and healthcare products and services to patients and healthcare institutions, strengthens its European growth with the acquisition of Replant 4 Care in Hungary. The Budapest-based company is a major player in the local ostomy, wound and continence care market. The transaction combines Replant 4 Care’s strong position in multiple market segments with Mediq’s local market leadership in wound care.

‘The strategic rationale for this combination is highly compelling’, says Christian Wojczewski, Mediq’s CEO. ‘At Mediq, our key priority is continuously raising the bar for care while ensuring healthcare access and affordability. The addition of the Replant 4 Care team allows us to expand into underserved market segments in Hungary. Leveraging the complementary strengths of both companies, we will be even better positioned to help those with a chronic or serious health issue.’

About Replant 4 Care
Replant 4 Care is a privately owned company that employs around 60 people (FTE) and has over 20 years of homecare experience. Replant 4 Care is market leader in ostomy care and the third largest wound care supplier in Hungary.

About Mediq
Every day, millions of patients and the dedicated professionals who care for them rely on the supply of medical devices and care solutions from Mediq. As a reliable partner for patients, healthcare professionals and healthcare insurers, Mediq continuously focuses on improving healthcare outcomes and the affordability of healthcare. Mediq was founded in 1899 and has leading market positions in 13 European countries. The head office is located in Utrecht.

22 October 2020 - Mediq intends to expand its position in the Benelux through the acquisition of Eurocept Homecare and Da Vinci Kliniek, both part of Eurocept Group. The acquisition is subject to approvals by regulatory authorities and expected to be completed in the upcoming months. Eurocept Homecare provides specialised medical care and ambulatory medical technology in the patient's home. Da Vinci Kliniek is a leading complex wound care and hyperbaric oxygen therapy expertise centre with six clinics across the Netherlands. Around 400 people work at these two organisations.

Christian Wojczewski, CEO Mediq Group: ‘Mediq Group is a leading international provider of medical devices and healthcare services. This acquisition in the Netherlands will complement and strengthen our portfolio of care solutions aimed at improving the quality of life for patients while making a contribution to keep healthcare affordable for everyone.’

Arjen Linders, Executive Vice President Benelux at Mediq adds: ‘With the complementary portfolios of Eurocept Homecare and Da Vinci Kliniek, we can provide better healthcare services outside the hospital. This is an excellent match with what we do best at Mediq: helping people with medical needs live their lives to the full potential and being there when they need us. There is a strong cultural fit between our respective organisations and we look forward to combining our strengths to drive our unique value proposition.’

Mike van Woensel, CEO Eurocept Group: ‘We are a leading pioneer in the field of specialised medical homecare and treatment for wound healing as well as skin and tissue damage. Mediq provides the scale and future-proof infrastructure to drive further development and growth. Furthermore, pooling our resources offers extra room to invest in technological innovation and digitisation. We have a lot to offer each other.’

Mediq, the European health care products and service partner for healthcare consumers, professionals and institutions, has acquired H&R Healthcare Ltd. A recognized leader in distribution of wound care products, H&R Healthcare significantly strengthens Mediq’s footprint in the UK. “Mediq is constantly innovating and investing in collaboration with healthcare providers to enable people with an illness or chronic health condition to live their lives on their own terms,” says Mediq Chief Executive Christian Wojczewski. “H&R Healthcare is the fastest growing distributor of our own brand wound care products. We look forward to working with their management and employees to provide the primary and secondary care market with the best possible products and services, specialist education and support.”

“Mediq and H&R Healthcare share a passion for delivering innovation to drive improved patient outcomes while simultaneously lowering the cost of delivering healthcare. Another thing that we have in common is our focus on outstanding products that meet patients’ needs and offer excellent value to the NHS”, adds Mike Hoskins, managing director of H&R Healthcare. “This transaction allows H&R Healthcare to grow its business in existing markets and expand in markets such as ostomy and continence care. Also, we will leverage and build upon our mutual wound care expertise to support the ongoing education of clinicians within the medical sector and develop new innovations that improve the health and well-being of patients.”

H&R Healthcare
H&R Healthcare was established in 2006, and has become one of the UK’s fastest growing medical sales and marketing distribution companies. H&R Healthcare represents world-class manufacturers of advanced wound management, compression, infection control, lymphoedema and skin protection products. All products are carefully selected to offer the best overall value to the NHS, measured by patient outcomes and overall cost effectiveness. The company is based in Hull and employs around 40 people.

This association focuses on improving prevention and care for the 1.2 million people in the Netherlands with chronic lung diseases. “We work on solutions for people with lung diseases in the areas of research, care improvement and self-management. Mediq is an important provider of medical devices and care services for people with respiratory diseases. We look forward to cooperating with Mediq and using their knowledge and expertise," LAN chairwoman Clémence Ross-Van Dorp says. In addition to companies such as Mediq, the LAN consists of patients, professional and industry associations, health insurers, funds and research and knowledge institutions.

Mediq Benelux has adjusted its commercial organization and strengthened its category management, sales and marketing functions. Vincent Bröring has been appointed as Sales Director, Roos Sorgdrager as Category Management Director and Marcia Luijendijk as Marketing Director. “Our new organizational structure enables a stronger customer focus. Under the leadership of Vincent, Roos and Marcia, our commercial triangle will work together to realize our ambitions and drive growth,” says Arjen Linders, Managing Director of Mediq Benelux.

Affordability and accessibility of care
This is a logical step in the transformation that Mediq started after the sale of its pharmacy activities. Since then, major changes have been made to strengthen direct-to-patient and institutional activities. Substantial investments were made in digitization, customer service processes and an ultramodern fulfillment center in Bleiswijk. Mediq also introduced multiple innovations that positively influence the care process and life of people with a chronic condition or illness. “In 2020 we are fully committed to growth as this enables us to keep providing affordable and accessible healthcare solutions," Linders says.

Arjen Linders has joined Mediq as Executive Vice President Benelux. Linders previously worked for Philips, amongst others as Senior Vice President & Market Leader Personal Health for North America. During his 20 years at this company, he fulfilled various management positions in personal health, personal care, sleep and respiratory care and consumer lifestyle. He worked in the Netherlands, Eastern Europe and the United States. At Mediq, he wants to leverage his broad experience to help guaranteeing the quality and affordability of healthcare.


Fresh perspective and new ideas
Mediq CEO Christian Wojczewski is pleased to have Linders on board of the European leadership team: ‘Mediq wants to change a market that is under pressure. Therefore, we are constantly expanding our circle of care, making new connections and developing e-health technologies. Arjen knows the healthcare market from working in multiple other branches than medical devices. His fresh perspective and new ideas are exactly what we need to be able to keep adding value.’

Stay healthy and self-reliant for longer‘
Every day, Mediq’s employees work hard to provide high-quality medical devices and care to improve the quality of life of people with a chronic or serious illness. A lot of attention is paid to innovations and opportunities to use technology to help people stay healthy and self-reliant for longer. I am thankful to be part of this professional organization’, Arjen Linders says.

Today Mediq acquired Puls AS, a major player in the Norwegian health market based in Moss, Norway. Puls is a distributor of medical consumables and capital goods in Norway and Denmark. This acquisition demonstrates our commitment to invest and grow our business in the Nordics cluster.
Our strategy for growth is based on three pillars: market leader in our core categories in the Homecare market, streamlined Total Assortment business for GPs, Care Institutions and Hospitals and leading provider in device-led Hospital Solutions. This acquisition strengthens Mediq’s leading position in Hospital Solutions in the Nordics region. We will combine Puls’ strong portfolio of exclusive products and technical expertise with Mediq’s leading position as a provider of hospital solutions across Europe.
Mediq Norge and Puls initially will continue to operate as separate entities and Puls will be managed by its existing management. Trond Dahl Hansen, Managing Director Puls, will report to Ilari Vaalavirta, Vice President Nordic Hospital Solutions Unit at Mediq. The Mediq Norge and Puls teams will move to a new location of which the search will start immediately. This acquisition further builds on our commitment to help those with a chronic or serious health issue, creating connections along the entire healthcare value chain. Our ambition is to grow by continuously raising the bar for care while ensuring affordability of healthcare. I am very pleased to welcome Puls to the Mediq family. The Puls team is complementing well our existing businesses in Norway and Denmark. We look forward to further develop, together with management and the employees, the successful Puls journey and become an even stronger partner for our customers, suppliers and patients in the Nordics region.

Mediq.com is using cookies

We use cookies to make Mediq websites easier to use, to deliver a personalised experience on our websites, and to better tailor our products, services and websites to your interests and needs.